Skip to main content

Editas Medicine, Inc 10-Q for FY2024 Q1

Editas Medicine, Inc. (EDIT)

10-Q 2024-05-08 For: 2024-03-31
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on May 8, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.14M
down 88.5% from $9.85M a year earlier
Net loss
$61.95M
compared with a net loss of $49.04M a year earlier
Diluted EPS
-$0.76
compared with -$0.71 a year earlier